전격성 A형간염의 임상양상 및 자발생존에 관한 예측인자
Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A
2
조회
0
다운로드
12
인용
0
참고문헌
키워드
초록
Backgrounds/Aims: The occurrence of acute hepatitis A is increasing and its progression to fulminant hepatic failure (FHF) is frequent. We investigated the frequency and clinical outcomes of fulminant hepatitis A and also analyzed the predictive factors of spontaneous survival. Methods: A total of 568 patients presented with acute hepatitis A from January 2003 to June 2008, of which the 35 (6.2%) patients with FHF were divided into two groups: spontaneous survival and transplant/death. These two groups were compared according to various clinical features including the MELD score and King’s College Hospital (KCH) criteria. Results: The rate of FHF development increased over time among patients with acute hepatitis A: 0% in 2003, 3.4% in 2004, 3.2% in 2005, 6.0% in 2006, 7.7% in 2007, and 13.0% in 2008. Twenty patients (57.1%) showed spontaneous survival, 13 (37.1%) received liver transplantation, and 5 (14.3%) died during hospitalization. The two groups of spontaneous survival (N=20) and transplant/death (N=15) showed significant differences in prothrombin time at admission and at its worst value, albumin at its worst value, and hepatic encephalopathy grade at admission and at its worst value. The MELD score was lower in the spontaneous-survival group than in the transplant/death group (27.0±7.8 vs. 37.0±7.1, mean±SD; P=0.001). However, KCH criteria did not differ significantly between the two groups. On multivariate analysis, HEP grade was the only significant predictive factor, being negatively correlated with spontaneous survival (OR=0.068, P=0.025). Conclusions: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
Abstract
Backgrounds/Aims: The occurrence of acute hepatitis A is increasing and its progression to fulminant hepatic failure (FHF) is frequent. We investigated the frequency and clinical outcomes of fulminant hepatitis A and also analyzed the predictive factors of spontaneous survival. Methods: A total of 568 patients presented with acute hepatitis A from January 2003 to June 2008, of which the 35 (6.2%) patients with FHF were divided into two groups: spontaneous survival and transplant/death. These two groups were compared according to various clinical features including the MELD score and King’s College Hospital (KCH) criteria. Results: The rate of FHF development increased over time among patients with acute hepatitis A: 0% in 2003, 3.4% in 2004, 3.2% in 2005, 6.0% in 2006, 7.7% in 2007, and 13.0% in 2008. Twenty patients (57.1%) showed spontaneous survival, 13 (37.1%) received liver transplantation, and 5 (14.3%) died during hospitalization. The two groups of spontaneous survival (N=20) and transplant/death (N=15) showed significant differences in prothrombin time at admission and at its worst value, albumin at its worst value, and hepatic encephalopathy grade at admission and at its worst value. The MELD score was lower in the spontaneous-survival group than in the transplant/death group (27.0±7.8 vs. 37.0±7.1, mean±SD; P=0.001). However, KCH criteria did not differ significantly between the two groups. On multivariate analysis, HEP grade was the only significant predictive factor, being negatively correlated with spontaneous survival (OR=0.068, P=0.025). Conclusions: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
참고문헌 (23)
- Song MH, "The etiology of acute viral hepatitis for the last 3 years", Korean J Med, 68, pp.256~260 (2005)
- Willner IR, "Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States", Ann Intern Med, 128, pp.111~114 (1998)
- Song YB, "The age-specific seroprevalence of hepatitis A virus antibody in Korea", Korean J Hepatol, 13, pp.27~33 (2007)
- Lemon SM, "value of immunization against hepatitis A", Infect Agents Dis, 3, pp.38~49 (1994)
- Koff RS, "Hepatitis A", Lancet, 351, pp.1643~1649 (1998)
- Schiodt FV, "Viral hepatitis-related acute liver failure", Am J Gastroenterol, 98, pp.448~453 (2003)
- Han SH, "An outbreak of hepatitis A in South Korea military personnel: A clinical and epidemiologic study", Korean J Hepatol, 7, pp.392~400 (2001)
- Kang HM, "Recent etiology and clinical features of acute viral hepatitis in a single center of Korea", Korean J Hepatol, 13, pp.495~502 (2007)
- Lee TH, "Clinical features of acute hepatitis A in the western part of Daejeon and Chungnam province: single center experience", Korean J Gastroenterol, 47, pp.136~143 (2006)
- Heo NY, "Clinical features of fulminant hepatic failure in a tertiary hospital with a liver transplant center in Korea", Korean J Hepatol, 12, pp.82~92 (2006)
- Shin SJ, "Clinical features and prognostic factors of fulminant hepatic failure in Koreans", Korean J Hepatol, 10, pp.298~307 (2004)
- Taylor RM, "Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes", Hepatology, 44, pp.1589~1597 (2006)
- Rezende G, "Viral and clinical factors associated with the fulminant course of hepatitis A infection", Hepatology, 38, pp.613~618 (2003)
- Yun H, "Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006", J Med Virol, 80, pp.777~784 (2008)
- Anand AC, "Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria", J Hepatol, 26, pp.62~68 (1997)
- Malinchoc M, "A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts", Hepatology, 31, pp.864~871 (2000)
- Kamath PS, "A model to predict survival in patients with end-stage liver disease", Hepatology, 33, pp.464~470 (2001)
- Kremers WK, "MELD score as a predictor of pretransplant and posttransplant survival in OPTN", UNOS status 1 patients, 2004, pp.39, 764~769
- Wiesner R, "Model for end-stage liver disease (MELD) and allocation of donor livers", Gastroenterology, 124, pp.91~96 (2003)
- Wasley A, "Incidence of hepatitis A in the United States in the era of vaccination", JAMA, 294, pp.194~201 (2005)
- Fiore AE, "Prevention of hepatitis A through active or passive immunization: recommendations of the advisory committee on immunization practices (ACIP)", MMWR Recomm Rep, 55, pp.1~23 (2006)
- 정숙향, "국내 A형간염의 현황과 백신 적응증", 대한소화기학회지, 51(6), pp.331~337 (2008), 대한소화기학회
- Victor JC, "Hepatitis A vaccine versus immune globulin for postexposure prophylaxis", N Engl J Med, 357, pp.1685~1694 (2007)